Onconetix ONCO Peer Comparison

NASDAQ ONCO
$0.81 -0.03 (-3.14%)
As of: Sep 9, 2026 · 3:59 PM EDT
Peer Comparison

300 Comparable Companies

Industry Diagnostic Equipment

Onconetix, Inc. (ONCO) is the 297th largest of 300 Diagnostic Equipment companies by market capitalisation, at 1.84 Mn, behind Bluejay Diagnostics, Inc. at 2.09 Mn. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 GEHC GE HealthCare Technologies Inc. primary H-08 Medical Devices and Diagnostics HG-02 29.54 Bn 14.41 1.39 27.44 Bn
2 LNTH Lantheus Holdings, Inc. primary H-08 Medical Devices and Diagnostics HG-02 6.56 Bn 23.84 4.22 5.97 Bn
3 HTFL Heartflow, Inc. primary H-08 Medical Devices and Diagnostics HG-02 4.04 Bn -166.44 19.90 3.66 Bn
4 NEOG Neogen Corp primary H-08 Medical Devices and Diagnostics HG-02 2.59 Bn -365.72 2.98 2.41 Bn
5 BFLY Butterfly Network, Inc. primary H-08 Medical Devices and Diagnostics HG-02 1.96 Bn -26.25 17.52 1.84 Bn
6 CBLL Ceribell, Inc. primary H-08 Medical Devices and Diagnostics HG-02 0.93 Bn -14.07 9.11 0.80 Bn
7 QDEL QuidelOrtho Corp primary H-08 Medical Devices and Diagnostics HG-02 0.87 Bn — — 0.74 Bn
8 VREX Varex Imaging Corp primary H-08 Medical Devices and Diagnostics HG-02 0.78 Bn 34.62 0.90 0.68 Bn
9 PRE Prenetics Global Ltd primary H-08 Medical Devices and Diagnostics HG-02 0.34 Bn -7.19 2.44 0.28 Bn
10 CV CapsoVision, Inc primary H-08 Medical Devices and Diagnostics HG-02 0.32 Bn -11.62 22.10 0.31 Bn
11 NNNN Anbio Biotechnology primary H-08 Medical Devices and Diagnostics HG-02 0.28 Bn 44.60 108.83 0.27 Bn
12 OSUR Orasure Technologies Inc primary H-08 Medical Devices and Diagnostics HG-02 0.24 Bn — 2,445.63 0.05 Bn
13 IMDX Insight Molecular Diagnostics Inc. primary H-08 Medical Devices and Diagnostics HG-02 0.15 Bn -2.77 90.00 0.13 Bn
14 HYPR Hyperfine, Inc. primary H-08 Medical Devices and Diagnostics HG-02 0.08 Bn -2.28 4.80 0.03 Bn
15 RTGN RetinalGenix Technologies Inc. primary H-08 Medical Devices and Diagnostics HG-02 0.08 Bn — — 0.08 Bn
16 RPID Rapid Micro Biosystems, Inc. primary H-08 Medical Devices and Diagnostics HG-02 0.06 Bn -1.16 1.69 0.04 Bn
17 MDAI Spectral AI, Inc. primary H-08 Medical Devices and Diagnostics HG-02 0.05 Bn -6.03 3.32 0.04 Bn
18 NNOX Nano-X Imaging Ltd. primary H-08 Medical Devices and Diagnostics HG-02 0.05 Bn -0.64 3.47 0.01 Bn
19 PAVM PAVmed Inc. primary H-08 Medical Devices and Diagnostics HG-02 0.03 Bn -1.07 230.71 0.03 Bn
20 QUCY Quantum Cyber N.V. primary H-08 Medical Devices and Diagnostics HG-02 0.02 Bn -1.01 — 0.01 Bn
21 AIFF Firefly Neuroscience, Inc. primary H-08 Medical Devices and Diagnostics HG-02 0.02 Bn -2.31 12.13 0.01 Bn
22 PLSM Pulsenmore Ltd. primary H-08 Medical Devices and Diagnostics HG-02 0.02 Bn 8.23 13.89 -0.01 Bn
23 ALRTF ALR Technologies SG Ltd. primary H-08 Medical Devices and Diagnostics HG-02 0.01 Bn -0.55 — 0.01 Bn
24 ADVB Advanced Biomed Inc. primary H-08 Medical Devices and Diagnostics HG-02 0.01 Bn 2.44 — 0.01 Bn
25 NDRA ENDRA Life Sciences Inc. primary H-08 Medical Devices and Diagnostics HG-02 0.01 Bn -1.33 — 0.00 Bn
26 BMRA Biomerica Inc primary H-08 Medical Devices and Diagnostics HG-02 0.01 Bn -2.17 1.46 0.01 Bn
27 CDIO Cardio Diagnostics Holdings, Inc. primary H-08 Medical Devices and Diagnostics HG-02 0.01 Bn -0.93 417.81 0.00 Bn
28 MBAI Check-Cap Ltd primary H-08 Medical Devices and Diagnostics HG-02 0.01 Bn 1.22 2.72 0.00 Bn
29 TRIB Trinity Biotech Plc primary H-08 Medical Devices and Diagnostics HG-02 0.01 Bn -0.16 0.13 0.01 Bn
30 INBS Intelligent Bio Solutions Inc. primary H-08 Medical Devices and Diagnostics HG-02 0.00 Bn -0.26 0.78 0.00 Bn
31 BJDX Bluejay Diagnostics, Inc. primary H-08 Medical Devices and Diagnostics HG-02 0.00 Bn -0.29 — 0.00 Bn
32 ONCO Onconetix, Inc. primary H-08 Medical Devices and Diagnostics HG-02 0.00 Bn -0.18 2.85 0.00 Bn
33 VNRX Volitionrx Ltd primary H-08 Medical Devices and Diagnostics HG-02 0.00 Bn -0.09 0.65 0.00 Bn
34 VRAX Virax Biolabs Group Ltd primary H-08 Medical Devices and Diagnostics HG-02 0.00 Bn -0.19 84.17 -0.01 Bn
35 HSCSW HeartSciences Inc. primary H-08 Medical Devices and Diagnostics HG-02 0.00 Bn -0.02 21.29 0.00 Bn
36 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 643.26 Bn 30.58 6.57 622.50 Bn
37 ABBV AbbVie Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 443.31 Bn 70.19 6.89 436.74 Bn
38 MRK Merck & Co., Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 364.74 Bn 115.10 5.48 357.60 Bn
39 TMO Thermo Fisher Scientific Inc. secondary H-10 Medical Devices and Diagnostics HG-02 225.48 Bn 32.03 4.87 221.41 Bn
40 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 211.73 Bn 24.22 5.56 197.74 Bn
41 ABT Abbott Laboratories secondary H-06 Medical Devices and Diagnostics HG-02 183.04 Bn 33.74 3.93 177.44 Bn
42 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 180.92 Bn -62.49 5.94 177.74 Bn
43 DHR Danaher Corp /De/ secondary H-10 Medical Devices and Diagnostics HG-02 144.42 Bn 36.20 5.75 140.08 Bn
44 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 132.16 Bn 30.00 10.50 124.30 Bn
45 ISRG Intuitive Surgical Inc secondary H-06 Medical Devices and Diagnostics HG-02 125.02 Bn 39.59 11.33 119.81 Bn
46 MDT Medtronic plc secondary H-06 Medical Devices and Diagnostics HG-02 117.84 Bn 22.36 3.14 109.02 Bn
47 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 82.89 Bn 19.15 5.34 74.90 Bn
48 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 61.41 Bn 35.80 11.75 56.23 Bn
49 CAH Cardinal Health Inc secondary H-19 Healthcare Payers and Distributors HG-05 56.55 Bn 33.17 0.22 51.69 Bn
50 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 53.99 Bn -17.13 24.23 48.85 Bn
51 SNY Sanofi secondary H-01 Pharmaceuticals and Biotechnology HG-01 52.33 Bn 11.23 0.98 44.95 Bn
52 BDX Becton Dickinson & Co secondary H-07 Medical Devices and Diagnostics HG-02 49.48 Bn 52.52 2.13 48.62 Bn
53 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.84 Bn 61.56 2.47 39.19 Bn
54 A Agilent Technologies, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 40.86 Bn 28.38 5.54 39.11 Bn
55 IDXX Idexx Laboratories Inc /De secondary H-05 Pharmaceuticals and Biotechnology HG-01 40.69 Bn 35.70 8.94 40.49 Bn
56 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 34.48 Bn 44.51 7.18 31.18 Bn
57 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 31.15 Bn 37.32 3.11 29.86 Bn
58 ILMN Illumina, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 30.97 Bn 37.54 6.89 29.80 Bn
59 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 30.05 Bn -20.25 2,751.33 30.05 Bn
60 MDLN Medline Inc. secondary H-07 Medical Devices and Diagnostics HG-02 29.24 Bn 28.30 1.02 26.56 Bn
61 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.99 Bn -31.97 24.60 26.83 Bn
62 INCY Incyte Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 25.23 Bn 15.65 4.34 20.69 Bn
63 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 23.72 Bn -13.92 7.67 10.06 Bn
64 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 18.20 Bn 21.48 2.14 17.79 Bn
65 FTV Fortive Corp secondary I-04 Machinery IG-02 17.01 Bn 31.84 3.94 16.64 Bn
66 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.87 Bn -49.74 12.36 15.03 Bn
67 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.87 Bn 18.30 11.19 14.92 Bn
68 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.65 Bn 22.19 4.64 15.26 Bn
69 JAZZ Jazz Pharmaceuticals plc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.22 Bn 16.17 3.31 13.60 Bn
70 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.90 Bn -21.53 20.89 14.18 Bn
71 EXEL Exelixis, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 14.62 Bn 16.98 6.00 13.78 Bn
72 RVTY Revvity, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 13.85 Bn 58.30 4.76 12.83 Bn
73 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.63 Bn — — 12.94 Bn
74 BAX Baxter International Inc secondary H-07 Medical Devices and Diagnostics HG-02 12.66 Bn 550.61 1.14 10.51 Bn
75 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.58 Bn 30.43 7.56 12.35 Bn
76 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.45 Bn 170.57 3.65 11.57 Bn
77 COO Cooper Companies, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 12.34 Bn 52.34 2.92 12.20 Bn
78 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 11.85 Bn -43.53 17.69 10.24 Bn
79 TECH BIO-TECHNE Corp secondary H-10 Medical Devices and Diagnostics HG-02 11.27 Bn 61.97 9.28 11.01 Bn
80 AAVXF Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
81 AXSM Axsome Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.89 Bn -70.84 14.02 10.57 Bn
82 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
83 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.11 Bn 18.88 3.21 9.51 Bn
84 BIO Bio-Rad Laboratories, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 10.11 Bn 45.45 3.90 8.49 Bn
85 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.05 Bn -26.35 — 9.29 Bn
86 RDY Dr Reddys Laboratories Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 9.91 Bn 785.46 2.70 9.74 Bn
87 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.56 Bn 86.62 33.92 9.56 Bn
88 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.24 Bn -43.52 10.57 7.18 Bn
89 GPCR Structure Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 8.96 Bn -47.63 — 8.96 Bn
90 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.59 Bn -8.13 — 8.59 Bn
91 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.47 Bn -8.54 51.11 8.12 Bn
92 BRKR Bruker Corp secondary H-10 Medical Devices and Diagnostics HG-02 8.30 Bn -77.68 2.37 8.09 Bn
93 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.97 Bn -14.81 — 7.97 Bn
94 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.77 Bn 17.59 9.72 7.09 Bn
95 GIFLF Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
96 OKLO Oklo Inc. secondary U-03 Power Generation UG-01 7.53 Bn -49.31 6,314.48 7.53 Bn
97 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.38 Bn -41.27 — 7.38 Bn
98 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.14 Bn -17.69 — 7.14 Bn
99 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.93 Bn -32.98 28.90 6.60 Bn
100 MMED MiniMed Group, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 6.37 Bn -20.43 2.00 6.17 Bn
101 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.36 Bn -28.39 1,021.85 6.36 Bn
102 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.31 Bn -704.68 4,533.84 6.31 Bn
103 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.25 Bn -7.27 10.12 5.82 Bn
104 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.09 Bn 75.51 7.24 5.56 Bn
105 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.87 Bn -16.20 — 5.87 Bn
106 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn -15.79 — 5.84 Bn
107 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.83 Bn -33.11 1,160.93 5.65 Bn
108 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn 29.31 19.90 4.42 Bn
109 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.74 Bn — — 4.01 Bn
110 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.62 Bn 14.70 5.57 3.39 Bn
111 STVN Stevanato Group S.p.A. secondary H-07 Medical Devices and Diagnostics HG-02 5.51 Bn 35.10 3.86 5.40 Bn
112 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.98 Bn -22.73 — 4.98 Bn
113 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.89 Bn -17.03 — 4.89 Bn
114 MIR Mirion Technologies, Inc. secondary I-39 Clean Energy Equipment IG-10 4.07 Bn 159.02 3.97 3.65 Bn
115 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.06 Bn -7.94 1,126.80 4.06 Bn
116 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.05 Bn — — 3.64 Bn
117 TLPPF Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 4.64 3.59 Bn
118 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.83 Bn -7.15 — 3.83 Bn
119 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.80 Bn -13.27 366.70 3.80 Bn
120 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.79 Bn -18.13 11.66 3.49 Bn
121 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.60 Bn -29.59 — 3.60 Bn
122 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.59 Bn -7.79 30.64 2.88 Bn
123 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.57 Bn -34.90 66.37 2.56 Bn
124 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.54 Bn -16.07 15.11 2.71 Bn
125 VCYT Veracyte, Inc. secondary H-17 Healthcare Providers HG-04 3.51 Bn 30.68 6.25 3.21 Bn
126 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.37 Bn -20.49 50.98 3.37 Bn
127 GRAL GRAIL, Inc. secondary H-17 Healthcare Providers HG-04 3.36 Bn -8.57 21.34 2.49 Bn
128 OSIS Osi Systems Inc secondary I-02 Aerospace and Defense IG-01 3.26 Bn 21.09 1.83 2.90 Bn
129 SXI Standex International Corp/De/ secondary I-04 Machinery IG-02 3.24 Bn 25.22 3.64 3.06 Bn
130 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.18 Bn -6.15 — 3.18 Bn
131 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.11 Bn 109.08 6.70 2.87 Bn
132 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.02 Bn -9.83 19,122.53 3.02 Bn
133 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.99 Bn -28.68 — 2.99 Bn
134 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -10.96 593.06 2.44 Bn
135 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.95 Bn -14.67 — 2.95 Bn
136 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.93 Bn -8.57 79.61 2.48 Bn
137 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.80 Bn -14.90 6.24 2.10 Bn
138 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.64 Bn -81.36 — 2.64 Bn
139 TAK Takeda Pharmaceutical Co Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.61 Bn 4.54 0.06 -3.19 Bn
140 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.58 Bn -8.52 49.52 2.58 Bn
141 CDNA CareDx, Inc. secondary H-17 Healthcare Providers HG-04 2.57 Bn 23.15 5.61 2.20 Bn
142 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.51 Bn -169.96 10.01 2.40 Bn
143 BEIGF BeOne Medicines Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.40 -2.62 Bn
144 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -6.10 — 2.44 Bn
145 SUPN Supernus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -28.71 3.10 2.07 Bn
146 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.41 Bn -20.29 44.17 1.73 Bn
147 HRMY Harmony Biosciences Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.41 Bn 13.50 2.51 1.60 Bn
148 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.40 Bn -5.99 33.69 2.40 Bn
149 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.33 Bn -16.97 1.18 1.53 Bn
150 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -2,975.41 — 2.29 Bn
151 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -5.95 4.28 1.94 Bn
152 NUVB Nuvation Bio Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.28 Bn -21.11 13.44 2.28 Bn
153 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn -36.49 12.04 2.16 Bn
154 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn -3.87 — 2.00 Bn
155 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.23 Bn -11.24 — 1.86 Bn
156 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.15 Bn 12.91 4.19 2.01 Bn
157 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.14 Bn 0.17 0.34 0.63 Bn
158 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.12 Bn -8.78 — 2.12 Bn
159 AUPH Aurinia Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.11 Bn 6.70 6.76 1.66 Bn
160 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -5.01 20.99 2.06 Bn
161 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -15.00 102.87 2.06 Bn
162 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.04 Bn -5.16 — 2.04 Bn
163 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.03 Bn -4.89 2,033.16 2.03 Bn
164 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -13.21 53.36 1.71 Bn
165 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -9.53 71.80 1.69 Bn
166 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.89 Bn -11.60 18.04 1.52 Bn
167 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.82 Bn -7.23 6.00 1.82 Bn
168 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.77 Bn -9.74 7.00 1.22 Bn
169 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.76 Bn -13.23 1,357.12 1.76 Bn
170 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.75 Bn -96.63 4.06 0.87 Bn
171 GLPGF Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
172 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.72 Bn -3.31 31.30 1.17 Bn
173 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -122.77 17.33 1.71 Bn
174 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -26.90 — 1.31 Bn
175 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -6.19 — 1.09 Bn
176 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -6.57 3.93 0.91 Bn
177 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -194.01 943.71 1.62 Bn
178 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -67.19 8.06 1.32 Bn
179 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -8.63 — 1.60 Bn
180 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn -10.33 523.75 1.59 Bn
181 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
182 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.54 Bn -9.11 20.12 1.26 Bn
183 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -3.17 2.04 1.17 Bn
184 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -17.48 — 1.46 Bn
185 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -13.63 72.27 1.45 Bn
186 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -9.37 50.20 0.81 Bn
187 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.44 Bn -26.48 5.56 1.03 Bn
188 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.43 Bn -9.65 — 1.43 Bn
189 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -8.67 — 1.42 Bn
190 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn -4.73 — 1.40 Bn
191 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn 82.16 36.50 1.40 Bn
192 ATEC Alphatec Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 1.40 Bn -12.73 1.72 1.28 Bn
193 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -9.82 — 1.37 Bn
194 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -11.30 876.13 1.17 Bn
195 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -8.64 — 1.36 Bn
196 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -6.49 — 1.33 Bn
197 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.27 Bn -1.37 — 1.27 Bn
198 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn -5.18 150.67 0.75 Bn
199 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.23 Bn -25.77 — 1.02 Bn
200 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -28.00 3.10 1.11 Bn
201 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -11.87 50.76 1.22 Bn
202 ASST Strive, Inc. secondary F-09 Asset and Wealth Management FG-03 1.18 Bn -2.97 4,532.77 1.11 Bn
203 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.16 Bn -7.56 — 1.16 Bn
204 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.14 Bn -19.84 — 1.14 Bn
205 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.12 Bn -4.64 22.98 0.66 Bn
206 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 6.67 5.60 0.92 Bn
207 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn -3.82 — 0.48 Bn
208 OKYO OKYO Pharma Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.99 Bn -118.02 — 0.99 Bn
209 WVE Wave Life Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -4.81 14.90 0.61 Bn
210 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -70.03 — 0.92 Bn
211 ARDX Ardelyx, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -17.06 2.11 0.67 Bn
212 GERN Geron Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -13.99 3.86 0.64 Bn
213 TBPH Theravance Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 20.84 8.45 0.49 Bn
214 RIGL Rigel Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 2.72 3.17 0.78 Bn
215 ANNX Annexon, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.87 Bn -4.26 — 0.87 Bn
216 STTK Shattuck Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.82 Bn -15.12 816.31 0.82 Bn
217 VSTM Verastem, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.80 Bn -6.91 9.10 0.66 Bn
218 AVTX Avalo Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.80 Bn -7.93 — 0.80 Bn
219 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -9.89 95.78 0.79 Bn
220 CTMX CytomX Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.77 Bn -10.21 42.29 0.44 Bn
221 PHAR Pharming Group N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.76 Bn -122.18 2.28 0.60 Bn
222 ZURA Zura Bio Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn -6.21 — 0.72 Bn
223 ZVRA Zevra Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.71 Bn 12.24 5.24 0.49 Bn
224 MLAB Mesa Laboratories Inc /Co/ secondary H-10 Medical Devices and Diagnostics HG-02 0.70 Bn 199.22 2.81 0.67 Bn
225 AURA Aura Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.68 Bn -6.22 — 0.61 Bn
226 IRWD Ironwood Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn 3.03 1.72 0.59 Bn
227 SLN Silence Therapeutics plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -16.42 1,038.05 0.57 Bn
228 CRMD CorMedix Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 5.07 1.70 0.38 Bn
229 ASMB Assembly Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn 502.49 8.35 0.30 Bn
230 ALT Altimmune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.62 Bn -8.43 — 0.62 Bn
231 CTKB Cytek Biosciences, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 0.61 Bn -7.63 2.97 0.54 Bn
232 CBIO Crescent Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -3.75 589.05 0.44 Bn
233 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -340,055.90 — 0.60 Bn
234 TECX Tectonic Therapeutic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -6.72 — 0.58 Bn
235 VALN Valneva SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.79 3.43 0.43 Bn
236 SGMT Sagimet Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -11.82 — 0.57 Bn
237 ARVN Arvinas, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn 61.21 1.80 0.00 Bn
238 CTNM Contineum Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.40 — 0.57 Bn
239 FLGT Fulgent Genetics, Inc. secondary H-17 Healthcare Providers HG-04 0.56 Bn -6.62 2.32 0.30 Bn
240 BBOT BridgeBio Oncology Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -2.72 — 0.32 Bn
241 OVID Ovid Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.53 Bn -15.37 334.91 0.41 Bn
242 OABI OmniAb, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -11.67 13.43 0.46 Bn
243 IMUX Immunic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -4.48 — 0.52 Bn
244 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -7.41 22.27 0.22 Bn
245 PRTA Prothena Corp Public Ltd Co secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn -11.04 8.89 0.20 Bn
246 CNTN Canton Strategic Holdings, Inc. secondary T-58 Fintech TG-09 0.48 Bn -5.85 330.55 0.48 Bn
247 KMDA Kamada Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 15.22 2.47 0.40 Bn
248 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.72 — 0.45 Bn
249 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -10.27 78.36 0.23 Bn
250 RLMD Relmada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -7.55 — 0.46 Bn
251 PBYI Puma Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 15.39 1.99 0.37 Bn
252 CYPH Cypherpunk Technologies Inc. secondary T-58 Fintech TG-09 0.45 Bn 7.62 — 0.45 Bn
253 DRUG Bright Minds Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -15.52 — 0.45 Bn
254 CCCC C4 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.44 12.85 0.20 Bn
255 AVIR Atea Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -3.09 — 0.42 Bn
256 RZLT Rezolute, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -5.18 — 0.42 Bn
257 ARCT Arcturus Therapeutics Holdings Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -4.40 14.27 0.23 Bn
258 CMPX Compass Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -5.07 — 0.41 Bn
259 BIOA BioAge Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -4.36 39.58 0.41 Bn
260 LRMR Larimar Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -2.28 — 0.24 Bn
261 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.14 39.23 0.19 Bn
262 ENTA Enanta Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -6.09 5.89 0.19 Bn
263 HMDCF HUTCHMED (China) Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
264 EYPT EyePoint, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.37 Bn -1.21 134.36 0.19 Bn
265 TKNO Alpha Teknova, Inc. secondary H-10 Medical Devices and Diagnostics HG-02 0.37 Bn -28.08 8.43 0.35 Bn
266 OFIX Orthofix Medical Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.36 Bn -8.34 0.44 0.26 Bn
267 CATX Perspective Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -3.02 — 0.36 Bn
268 OCGN Ocugen, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -4.39 78.38 0.26 Bn
269 WHWK Whitehawk Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn -4.36 — 0.35 Bn
270 FHTX Foghorn Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -5.03 9.00 0.26 Bn
271 UPB Upstream Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -2.03 102.81 0.32 Bn
272 ELDN Eledon Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.86 — 0.32 Bn
273 EPRX Eupraxia Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -6.37 — 0.32 Bn
274 CLLS Cellectis S.A. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -7.50 5.28 0.14 Bn
275 STRO Sutro Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -2.69 3.39 0.14 Bn
276 TRDA Entrada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -1.82 64.42 0.30 Bn
277 MYGN Myriad Genetics Inc secondary H-17 Healthcare Providers HG-04 0.30 Bn -2.67 0.37 0.19 Bn
278 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 3.08 2.13 0.28 Bn
279 EQ Equillium, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -15.70 — 0.28 Bn
280 BCYC Bicycle Therapeutics Plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.46 4.56 0.28 Bn
281 TLSI TriSalus Life Sciences, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.28 Bn -4.74 6.17 0.23 Bn
282 ACIU AC Immune SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -5.13 12.56 0.28 Bn
283 SABS SAB Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -4.04 — 0.28 Bn
284 GALT Galectin Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -9.52 — 0.27 Bn
285 MGNX Macrogenics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -16.20 1.56 0.15 Bn
286 AKBA Akebia Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -8.70 1.18 0.10 Bn
287 ANTX AN2 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -7.05 — 0.26 Bn
288 FIXX Q32 Bio Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 63.96 — 0.15 Bn
289 AVXL Anavex Life Sciences Corp. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -18.19 — 0.14 Bn
290 IVVD Invivyd, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.01 4.50 0.09 Bn
291 ALXO Alx Oncology Holdings Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.12 — 0.25 Bn
292 RELL Richardson Electronics, Ltd. secondary I-07 Machinery IG-02 0.25 Bn 42.88 1.11 0.22 Bn
293 CAMP Camp4 Therapeutics Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -5.05 59.91 0.25 Bn
294 ALEC Alector, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -2.87 18.17 0.08 Bn
295 CYDY CytoDyn Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -7.46 — 0.25 Bn
296 TARA Protara Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.34 — 0.23 Bn
297 CELG-RI Bristol Myers Squibb Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.03 0.00 -10.83 Bn
298 SRZN Surrozen, Inc./DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.80 20.14 0.23 Bn
299 CGEN Compugen Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 6.54 3.11 0.14 Bn
300 KRRO Korro Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.77 96.15 0.11 Bn